Login
← Go Back
Laurus Labs
LAURUSLABS · Pharma > Pharmaceuticals & Drugs · Chairman: M Venu Gopala Rao Listing date: Dec. 20, 2016 · Employees: 4808 · Hyderabad · http://www.lauruslabs.com
Stock Price vs Company Growth
1d
2.6%
1w
10.4%
1m
21.2%
3m
59.2%
6m
76.0%
1y
98.2%
5y
23.6%
all
35.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,758 2.6%
1,079
1,762
Company Overview
Sales
7,270 Cr
Growth: 15.1%
Profit after Tax
1,093 Cr
Growth: 23.0%
Large Cap
94,987 Cr
P/E: 86.9x
Industry P/E: 32.3x
Fundamentals
Sales (Cr) ₹ 7,270
Growth 15.1%
EBITDA 28.0%
P/S 13.1x
Dividend 0.2%
P/E 86.9x
Book Value ₹ 105
PEG Ratio 5.7x
ROE 20.9%
P/B 16.8x
Shareholding Pattern
Institutions
Amansa Holdings Private Limited
4.8 %
Anukar Projects Private Limited
3.2 %
Kalidindi Srihari Raju
3.04 %
New World Fund Inc
2.02 %
Societe Generale
1.23 %
Promoters
Satyanarayana Chava
16.58 %
Chava Naga Rani
6.55 %
Venkata Lakshman Rao Chunduru
2.51 %
Venkata Ravi Kumar Vantaram
1.44 %
Hymavathi Vantaram
0.04 %
Others
Increase    Decrease    No change
Company Profile Detailed
Laurus Labs is a research-driven pharmaceutical and biotechnology company committed to fostering sustainable growth and innovation in the pharmaceutical space globally. The company is an integrated pharmaceutical company, offering one-stop solution from clinical stage development to manufacturing scale.
Belongs to (47 Indices) view more
Investors (166)
veeraiah...
ramachan...
v.uma.ma...
Followers (8)
sunit
chanakya...
ravi_sha...